Ionis Pharmaceuticals, Inc. (IONS)
IONS price $44.55 -0.85 -1.87%
- Ticker
- IONS
- Price
- $44.55
- Change
- -0.85 -1.87%
- Market cap
- $7.40B
- P/E
- -16.98
- Forward P/E
- 239.41
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 48
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy…